Main Article

As genetic testing becomes more widely embedded in clinical practice and as technological advances transform the way the testing is performed, what adaptations are needed in federal oversight policy to address quality and safety concerns, and what value for patients would be gained by additional and/or revised government regulation?

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

December 17, 2007 - Table of Contents

NIR December 17, 2007 (full PDF issue)

CMS Forging Ahead with Lab Bidding Demo in San Diego

Time Running Out for Physician Fee Fix

Advisory Panel Prescribes Changes for CMS, FDA in Genetic Test Oversight

January 1—Key Deadline for Use of National Provider Identifier

Medicare Improper Claims Payment Continues to Drop